TCGX Acquisition Corp. (TCGX) Prices $75M IPO

by Kristi Marvin on 2026-08-04 at 8:02pm

TCGX Acquisition Corp. (NASDAQ:TCGX) announced the pricing of its $75 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “TCGX” on Wednesday, August 5, 2026.

The new SPAC intends to focus on companies in the healthcare and healthcare-related industries. In particular, the team intends to target companies in the life sciences and medical technology sectors, where they have extensive investment experience.

TCGX Acquisition Corp. is to be led by Chief Executive Officer and Director Chen Yu, M.D., M.B.A. and Chief Financial Officer and Director Craig Skaling. Andrew Cheng, M.D. Ph.D., Ying Huang, Ph.D. and Wei Lin, M.D. will serve on its Board of Directors.

Total SPAC deal count for 2026 year-to-date is now 138. This offering is expected to close on Thursday, August 6, 2026.

Jefferies is acting as the sole book running manager for the offering. Latham & Watkins LLP is serving as Issuer’s Counsel with Goodwin Procter LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Odyssey Transfer and Trust Company is acting as trustee.